Research

Estimates

SA Earngings
MB Earnings
Yahoo Earnings
CNBC Earnings
Barrons Earnings

Ratings

SA Ratings
MB Ratings
BC Ratings
TR Ratings
Fidelity

Short Interest

MB Shorts
Quandl

Smart Money

MB Institutional
Gurus

Options

BC Options Ratio

Financials

GuruFocus Summary

Social

Stocktwits
MB Social
SocialSentiment.com
Twitter
Yahoo
Facebook
Reuters
Google

Misc

Tickeron
Ycharts NAV +/-

Intensity Therapeutics, Inc. Common Stock | INTS

AI Analysis of Intensity Therapeutics, Inc. Common Stock

Investors didn't show much interest in one Intensity Therapeutics way or another today. It hasn't moved too much today but is slightly down, it lost -0.23% since yesterday.

The company isn't at an immediate support or resistance level that might be predictive. Intensity Therapeutics hasn't shown a lot of strength recently, shareholders don't seem that energized about the asset's future prospects. INTS might find some support at the 5.97 level, buyers might push the price back up from here. But it's not very clear what will happen.


Last analyzed on 2026-07-23

Research

Estimates

SA Earngings
MB Earnings
Yahoo Earnings

Ratings

SA Ratings
MB Ratings
BC Ratings
TR Ratings
Fidelity

Short Interest

MB Shorts
Quandl

Smart Money

MB Institutional
Gurus

Options

BC Options Ratio

Financials

GuruFocus Summary

Social

MB Social
SocialSentiment.com
Twitter
Yahoo
Facebook
Reuters
Google

Misc

Tickeron
Ycharts NAV +/-